HOME        |         CONFERENCE AGENDA         |          SPEAKERS          |         DEAL OF THE YEAR        |          REGISTER           |      CONTACT US
ALLICENSE DEAL OF THE YEAR NOMINEES TO PRESENT AT ALLICENSE 2016. We are thrilled to have representatives from the buyside and sellside of each of the 10 nominated deals (5 M&A and 5 licensing transactions) present during the Allicense 2016 Breakthrough Deal of the Year Nominees rapid-fire presentation scheduled for 2:15 – 3:15 PM. Nominees were announced May 3.

Meet the speakers representing the nominees below. 
CLAIRE NAUSSAC, 
Innate 
(AstraZeneca/Innate alliance)
SAMARTH KULKARNI,
CRISPR
(Vertex/CRISPR alliance)

PAUL VAN DER HORST, 
Galapagos 
(Gilead/Galapagos alliance)

BARRY KENNY, 
Heptares 
(Pfizer/Heptares alliance)
PHIL MCGURK
Pfizer
(Pfizer/Heptares alliance)
DR. MARTIN CROOK,
Bristol-Myers Squibb
(Bristol-Myers Squibb/Cardioxyl alliance)
DR. WILLIAM SHEN,
Bristol-Myers Squibb
(Bristol-Myers Squibb/Cardioxyl alliance)
DR. JEFFREY A. STAFFORD
Celgene Quanticel Research
(Celgene/Quanticel alliance)
MICHAEL ATTAR
Celgene
(Celgene/Quanticel alliance)
ZUBIN BHAGWAGAR
Alexion
(Alexion/Synageva alliance)
MARK BARRETT
Genzyme
(Sanofi(Genzyme)/Voyager Therapeutics alliance)
SHANNON RYAN
Gilead
(Gilead/Galapagos alliance)
JAMES DOUGHERTY
Roche
(Roche/Foundation Medicine alliance)